Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6169)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kruger S, Haas M, Ormanns S, Bächmann S, Siveke JT, Kirchner T, Heinemann V, Boeck S. Translational research in pancreatic ductal adenocarcinoma: Current evidence and future concepts. World J Gastroenterol 2014; 20(31): 10769-10777 [PMID: 25152580 DOI: 10.3748/wjg.v20.i31.10769] |
|---|---|
| URL: | https://www.wjgnet.com/2644-3236/full/v20/i31/10769.htm |
| Number | Citing Articles |
| 1 |
Sentia Iriana, Shahzad Ahmed, Jun Gong, Alagappan Anand Annamalai, Richard Tuli, Andrew Eugene Hendifar. Targeting mTOR in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00099
|
| 2 |
Steffen Ormanns, Michael Haas, Anna Remold, Stephan Kruger, Stefan Holdenrieder, Thomas Kirchner, Volker Heinemann, Stefan Boeck. The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy. International Journal of Molecular Sciences 2017; 18(5): 1094 doi: 10.3390/ijms18051094
|
| 3 |
Sibylle Baechmann, Steffen Ormanns, Michael Haas, Stephan Kruger, Anna Remold, Dominik Paul Modest, Thomas Kirchner, Andreas Jung, Jens Werner, Volker Heinemann, Stefan Boeck. Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3376-4
|
| 4 |
Carole Vitellius, Caroline Eymerit-Morin, Dominique Luet, Lionel Fizanne, Fanny Foubert, Sandrine Bertrais, Marie-Christine Rousselet, François-Xavier Caroli-Bosc. Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX. Clinical Drug Investigation 2017; 37(7): 669 doi: 10.1007/s40261-017-0522-3
|
| 5 |
Diana Behrens, Wolfgang Walther, Iduna Fichtner. Pancreatic cancer models for translational research. Pharmacology & Therapeutics 2017; 173: 146 doi: 10.1016/j.pharmthera.2017.02.013
|
| 6 |
Stephan Kruger, Michael Haas, Philipp Johannes Burger, Steffen Ormanns, Dominik Paul Modest, Christoph Benedikt Westphalen, Axel Kleespies, Martin Kurt Angele, Werner Hartwig, Christiane Josephine Bruns, Thomas Kirchner, Jens Werner, Volker Heinemann, Stefan Boeck. Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2585 doi: 10.1007/s00432-016-2264-7
|
| 7 |
Michael Haas, Steffen Ormanns, Sibylle Baechmann, Anna Remold, Stephan Kruger, Christoph B Westphalen, Jens T Siveke, Patrick Wenzel, Anna Melissa Schlitter, Irene Esposito, Detlef Quietzsch, Michael R Clemens, Erika Kettner, Ruediger P Laubender, Andreas Jung, Thomas Kirchner, Stefan Boeck, Volker Heinemann. Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer. British Journal of Cancer 2017; 116(11): 1462 doi: 10.1038/bjc.2017.115
|
| 8 |
Hanieh Azari, Elham Nazari, Hamid Jamialahmadi, Ghazaleh Khalili-Tanha, Mina Maftooh, Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Amir Avan. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. 2024; : 317 doi: 10.1016/B978-0-443-19142-8.00010-3
|
| 9 |
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
|
| 10 |
Enze Liu, Zhuang Zhuang Zhang, Xiaolin Cheng, Xiaoqi Liu, Lijun Cheng. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma. BMC Medical Genomics 2020; 13(S5) doi: 10.1186/s12920-020-0681-6
|
| 11 |
Vickna Balarajah, Archana Ambily, Abu Z Dayem Ullah, Ahmet Imrali, Thomas Dowe, Bilal Al-Sarireh, Mohammed Abu Hilal, Brian R Davidson, Zahir Soonawalla, Matthew Metcalfe, Jo-Anne Chin Aleong, Claude Chelala, Hemant M Kocher. Pancreatic cancer tissue banks: where are we heading?. Future Oncology 2016; 12(23): 2661 doi: 10.2217/fon-2016-0243
|
| 12 |
Dadong Wang, Jingwang Tan, Yong Xu, Mingming Han, Yuliang Tu, Ziman Zhu, Chunqing Dou, Jin Xin, Xianglong Tan, Jian-ping Zeng, Gang Zhao, Zhiwei Liu. The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma. Tumor Biology 2016; 37(1): 627 doi: 10.1007/s13277-015-3499-7
|
| 13 |
Archana Bhaw-Luximon, Dhanjay Jhurry. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery. Cancer Letters 2015; 369(2): 266 doi: 10.1016/j.canlet.2015.09.007
|
| 14 |
Cristina Arqueros, Juliana Salazar, M. J. Arranz, Ana Sebio, Josefina Mora, Ivana Sullivan, María Tobeña, Marta Martín-Richard, Agustí Barnadas, Montserrat Baiget, David Páez. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients. Medical Oncology 2017; 34(8) doi: 10.1007/s12032-017-0993-3
|
| 15 |
Varshini Vasudevaraja, Jamie Renbarger, Ridhhi Girish Shah, Garrett Kinnebrew, Murray Korc, Limei Wang, Yang Huo, Enze Liu, Lang Li, Lijun Cheng. PMTDS: a computational method based on genetic interaction networks for Precision Medicine Target‐Drug Selection in cancer. Quantitative Biology 2017; 5(4): 380 doi: 10.1007/s40484-017-0126-1
|
| 16 |
Steffen Ormanns, Michael Haas, Sibylle Baechmann, Annelore Altendorf-Hofmann, Anna Remold, Detlef Quietzsch, Michael R Clemens, Martin Bentz, Michael Geissler, Helmut Lambertz, Stephan Kruger, Thomas Kirchner, Volker Heinemann, Stefan Boeck. Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials. British Journal of Cancer 2016; 115(12): 1520 doi: 10.1038/bjc.2016.355
|
| 17 |
Stephan Kruger, Michael Haas, Philipp Johannes Burger, Steffen Ormanns, Dominik Paul Modest, Christoph Benedikt Westphalen, Marlies Michl, Axel Kleespies, Martin Kurt Angele, Werner Hartwig, Christiane Josephine Bruns, Maximilian Niyazi, Falk Roeder, Thomas Kirchner, Jens Werner, Volker Heinemann, Stefan Boeck. Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. Pancreatology 2016; 16(4): 593 doi: 10.1016/j.pan.2016.03.016
|
| 18 |
S. Kruger, V. Heinemann, C. Ross, F. Diehl, D. Nagel, S. Ormanns, S. Liebmann, I. Prinz-Bravin, C.B. Westphalen, M. Haas, A. Jung, T. Kirchner, M. von Bergwelt-Baildon, S. Boeck, S. Holdenrieder. Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer. Annals of Oncology 2018; 29(12): 2348 doi: 10.1093/annonc/mdy417
|